Greater trochanteric pain syndrome (GTPS) is a common problem with an incidence of 1.8–5.6 per 1000 population. Physiotherapy, anti-inflammatories, corticosteroid injections and surgery have all been described in the management of GTPS, with limited, temporal success. Extracorporeal shockwave therapy (ESWT) has been proposed as a potential non-invasive management option for this difficult presentation.
Method:
We ran a prospective, 2-arm, single-blinded, randomised control trial comparing focused shockwave therapy (f-ESWT) to an ultrasound guided corticosteroid injection. Primary outcome measure was the visual analogue pain score. Secondary outcome measures included the Harris Hip Score (HHS) and Trendelenburg test for function; SF-36 for quality of life (QoL); and a Likert scale question for subjective assessment of symptom improvement.
Results:
104 patients (10 males and 94 females), of mean age 61.5 years were recruited. 53 were randomised to receive ESWT and 51 to receive an image-guided injection. 11 patients were lost to follow-up. There were no significant differences in baseline scores between groups.
At 3 months, pain, function and QoL scores had improved in both groups but were not statistically significant. The Trendelenburg test was significantly improved in the f-ESWT group with 80% patients being negative compared to 20% at baseline (p< 0.001).
At 12 months, across all outcomes, the ESWT group had significantly improved scores compared to the injection group; VAS 37.1 versus 55.0 (p = 0.007, 95% confidence interval [CI], 6.3–30.8), HHS 69.7 versus 57.5 (p = 0.002, 95% CI, −20.0 to −4.6) and SF-36 52.4 versus 47.7 (p = 0.048, 95% CI, −9.31 to −0.04). The improvement in Trendelenburg test was maintained in the ESWT group, but the injection group had reverted to baseline (p < 0.001).
Conclusions:
We have shown f-ESWT is an effective treatment for patients with GTPS. We would advocate f-ESWT as an effective non-invasive treatment modality for this challenging patient population.
WilliamsBSCohenSP. Greater trochanteric pain syndrome: a review of anatomy, diagnosis and treatment. Anesth Analg2009; 1085: 1662–1670.
2.
BrinksAvan RijnRMBohnenAM, et al. Effect of corticosteroid injection for trochanteric pain syndrome: design of a randomized clinical trial in general practice. BMC Musculoskelet Disord2007; 8: 95.
3.
SegalNAFelsonDTTornerJC, et al. Greater trochanteric pain syndrome: epidemiology and associated factors. Arch Phys Med Rehabil2007; 88: 988–992.
4.
KongAvan der ViletAZadowS. MRI and US of gluteal tendinopathy in greater trochanteric pain syndrome. Eur Radiol2007; 17: 1772–1783.
5.
De BuonoAPapaliaRKhandujaV, et al. Management of the greater trochanteric pain syndrome: a systematic review. Br Med Bull2012; 102: 115–131.
6.
GrimaldiAMellorRHodgesP, et al. Gluteal tendinopathy: a review of mechanisms, assessment and management. Sports Med2015; 45: 1107–1119.
7.
AndersonKStricklandSMWarrenR. Hip and groin injuries in athletes. Am J Sports Med2001; 29: 521–533.
8.
FearonAMCookJLScarvellJM, et al. Greater trochanteric pain syndrome negatively affects work, physical activity and quality of life: a case control study. J Arthroplasty2014; 29: 383–386.
9.
AliMOderuthEAtchiaI, et al. The use of platelet-rich plasma in the treatment of greater trochanteric pain syndrome: a systematic literature review. J Hip Preserv Surg2018; 5: 209–219.
10.
GovaertLHvan der VissHMMartiRK, et al. Trochanteric reduction osteotomy as a treatment for refractory trochanteric bursitis. J Bone Joint Surg Br2003; 85: 199–203.
11.
SlawskiDPHowardRF. Surgical management of refractory trochanteric bursitis. Am J Sports Med1997; 25: 86–89.
12.
BakerCL JrMassieRVHurtWG, et al. Arthroscopic bursectomy for recalcitrant trochanteric bursitis. Arthroscopy2007; 23: 827–832.
13.
DrummondJFaryCTranP. The outcome of endoscopy for recalcitrant greater trochanteric pain syndrome. Arch Orthop Trauma Surg2016; 136: 1547–1554.
14.
RompeJDSegalNACacchioA, et al. Home training, local corticosteroid injection or radial shockwave therapy for greater trochanteric pain syndrome. Am J Sports Med2009; 37: 1981–1990.
15.
BrinksAvan RijnRMWillemsenSP, et al. Corticosteroid injection for greater trochanteric pain syndrome: a randomized controlled trial in primary care. Ann Fam Med2011; 9: 226–234.
16.
CohenSPStrasselsSAFosterL, et al. Comparison of fluoroscopically guided and blind corticosteroid injections for greater trochanteric pain syndrome: multicentre randomized controlled trial. BMJ2009; 338: b1088.
17.
LustenbergerDPNgVYBestTM, et al. Efficacy of treatment of trochanteric bursitis: a systematic review. Clin J Sport Med2011; 21: 447–453.
FuriaJPRompeJDMaffulliN. Low-energy extracorporeal shock wave therapy as a treatment for greater trochanteric pain syndrome. Am J Sports Med. 2009; 37: 1806–1813.
20.
ShbeebMIO’DuffyJDMichetCJ Jr, et al. Evaluation of glucocorticosteroid injection for the treatment of trochanteric bursitis. J Rheumatol1996; 23: 2104–2106.
21.
Ege RasmussenKJFanoN. Trochanteric bursitis: treatment by corticosteroid injection. Scand J Rheumatol1985; 14: 417–420.
22.
WangCJ. An overview of shockwave therapy in musculoskeletal disorders. Chang Gung Med J2003; 26: 220–232.
Mani-BabuSMorrisseyDWaughC, et al. The effectiveness of extracorporeal shock wave therapy in lower limb tendinopathy: a systematic review. Am J Sports Med2015; 43: 752–761.
26.
MoyaDRamónSSchadenW, et al. The role of extracorporeal shockwave treatment in musculoskeletal disorders. J Bone Joint Surg Am2018; 100: 251–263.
van der WorpHZwerverJHamstraM, et al. No difference in effectiveness between focused and radial shockwave therapy for treating patellar tendinopathy: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc2014; 22: 2026–2032.
29.
BarrattPABrookesNNewsonA. Conservative treatments for greater trochanteric pain syndrome: a systematic review. Br J Sports Med2017; 51: 97–104.
30.
RamonSRussoSSantoboniF, et al. Focused shockwave therapy for greater trochanteric pain syndrome. J Bone Joint Surg Am2020; 102: 1305–1311.
31.
CarlisiECeciniMDi NataliG, et al. Focused extracorporeal shock wave therapy for greater trochanteric pain syndrome with gluteal tendinopathy: a randomized controlled trial. Clin Rehabil2019; 33: 670–680.
32.
National Institute for Health and Clinical Excellence. Interventional procedure: overview for refractory greater trochanteric pain syndrome. IP 858, 2010.
33.
National Institute for Health and Clinical Excellence. Interventional Procedures Guidance. Extracorporeal shockwave therapy for refractory greater trochanteric pain syndrome. IPG 376. NICE, 2011.
34.
National Institute for Health and Clinical Excellence. Understanding NICE Guidance: treating greater trochanteric pain syndrome using shockwave therapy. Information about NICE interventional procedure guidance 376. NICE, 2011.
35.
PriceDDMcGrathPARafiiA, et al. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain1983; 17: 45–56.
36.
MahomedNNArndtDCMcGoryBJ, et al. The Harris hip score: comparison of patient self-report with surgeon assessment. J Arthroplasty2001; 16: 575–580.
37.
LequesneMMathieuPVuillemin-BodaghiV, et al. Gluteal tendonpathy in refractory greater trochanter pain syndrome: diagnostic value of two clinical tests. Arth Rhem200859: 241–246.
38.
McHorneyCAWareJE JrRaczekAE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.Med Care1993; 31: 247–263.
39.
FriedeTKieserM. Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis. Pharm Stat2011; 10: 8–13.
40.
FarrarJTYoungJP JrLaMoreauxL, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain2001; 94: 149–158.
41.
CohenJ. Statistical power analysis for the behavioral sciences. 2nd ed.Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
42.
NormanGRSloanJAWyrwichKW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care2003; 41: 582–592.
43.
SchulzKFAltmanDGMoherD; for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. BMJ2010; 340: c332.
44.
SchmitzC. Focused and radial extracorporeal shock wave therapy: more similarities than differences. Physiotherapy2015; 101(Suppl. 1): e1346–e1347.
45.
SeoKHLeeJYYoonK, et al. Long-term outcome of low-energy extracorporeal shockwave therapy on gluteal tendinopathy documented by magnetic resonance imaging. PLoS One2018; 13: e0197460.
FosterTEPuskasBLMandelbaumBR, et al. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med2009; 37: 2259–2272.
48.
BrookerAF Jr. The surgical approach to refractory trochanteric bursitis. Johns Hopkins Med J1979; 145: 98–100.
49.
MellorRBennellKGrimaldiA, et al. Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial. BMJ2018; 361: k1662.
